Research and Development Tax Relief– Updated HMRC Guidance for Software & IT Projects
We’ve teamed up with Annette Beresford from Jurit LLP, who have recently been awarded ‘Most Pragmatic Legal Solutions Provide 2019’ in the UK Enterprise Awards, to write this article as we share a very...
Cell line technology
By Frances Griss
One of the most exciting and rapidly growing fields of bioscience is the development of new cell lines with specific and controllable characteristics, either for research or industrial scale production.
Companies all over...
Closing the Loop on personalised healthcare
Precision medicine using personalised treatments has entered mainstream healthcare. Closed Loop Medicine Ltd aims to level the playing field further with its drug and digital combination products.
The Cambridge-based healthcare company is developing drug and...
Do AI models and the human brain process things in the same way?
Deep Neural Networks – part of the broader family of machine learning – have become increasingly powerful in everyday real-world applications such as automated face recognition systems and self-driving cars.
Researchers use Deep Neural Networks,...
Taking a global view
Work being done by Romanian and Ukranian scientists in the Danube Delta is helping to drive a research programme that could have global ramifications.
Findings by the Danube Delta Research Institute show that algae bloom...
Advances in analytical characterisation of biosimilars
The substantial improvement in the power of analyticalmethods to compare different versions of a givenprotein molecule should be taken into account whenconsidering the need for clinical studies for designation ofbiosimilarity. Arguably, demonstration of comparative...
Harnessing pharmacogenomics for better health outcomes
In this issue, we speak to Dr Jerika Lam of the School of Pharmacy at Chapman University, about her work applying pharmacogenomics to antiviral treatments.
“A lot has happened in the field of hepatitis C...
The body in miniature
By Craig Brierley at University of Cambridge
The past few years has seen an explosion in the number of studies using organoids – so-called ‘mini organs’. While they can help scientists understand human biology and...
Nanochannels light the way to new medicine
The development of new drugs and vaccines requires detailed knowledge about nature’s smallest biological building blocks – biomolecules. Swedish researchers have devised a new microscopy technique that allows proteins, DNA and other tiny biological...
New link between gut microbiome and artery hardening discovered
The gut microbiome is under increasing scrutiny in medical research as it is known to affect many different aspects of our health, including our metabolism and auto-immune system. A lack of diversity or range...
Light therapy helmet could help dementia patients
A new infrared light therapy has the potential to help people with dementia.
A pilot study recently investigated how transcranial photobiomodulation therapy (PBM-T) –transferred through a specially adapted helmet -- could boost memory, motor function...
Storage crucial to American cancer initiative
The management of information is also at the heart of The Genomic Data Commons (GDC) initiative in the United States, a system backed by the US Government to promote sharing of genomic and clinical...
COVID-19 deaths among elderly may be due to genetic limit on cell division
Your immune system’s ability to combat COVID-19, like any infection, largely depends on its ability to replicate the immune cells effective at destroying the SARS-CoV-2 virus that causes the disease. These cloned immune cells...
Nanomedicine – bridging the skills gap
Nanomedicine is at the forefront of modern healthcare. Nanoparticles offer a new platform for drug delivery that can extend the “patent life” of drugs, but also greatly increase the targeting and effectiveness of therapy.
In...
Over three million surgical operations and cancer treatments a year in England may become...
New data published by Public Health England (PHE) show that antibiotic resistant bloodstream infections continue to rise in England, with an estimated 35% increase from 2013 to 2017 (from 12,250 in 2013 to...
Conference to turn spotlight on biosimilars market
Biologics and biosimilars researchers from around the globe will gather for the 7th European Biosimilars Congress 2017 in Munich between
May 15-17.
The congress will bring together everyone from scientists, researchers and business development managers to...